Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Rocchi

Showing results (71-80 of 81) with videos related to

Pageof 9
Sort By:
The Journal of Clinical Endocrinology and Metabolism|January 22, 1998
Outcome of thyroid function in Graves' patients treated with radioiodine: role of thyroid-stimulating and thyrotropin-blocking antibodies and of radioiodine-induced thyroid damageL Chiovato, E Fiore, P Vitti, et al.
Revue D'Electroencephalographie Et De Neurophysiologie Clinique|December 1, 1983
EEG sleep patterns and endogenous opioids in infants of narcotic-addicted mothersL G Manfredi, R Rocchi, A E Panerai, et al.
Neurology|July 17, 1999
A new CACNA1A gene mutation in acetazolamide-responsive familial hemiplegic migraine and ataxiaS Battistini, S Stenirri, M Piatti, et al.
Journal of Endocrinological Investigation|June 21, 2018
Relationship between serum cholesterol and Graves' orbitopathy (GO): a confirmatory studyG Lanzolla, E Sabini, M A Profilo, et al.
Journal of Endocrinological Investigation|January 19, 2015
Long-term outcome of Graves' orbitopathy following high-dose intravenous glucocorticoids and orbital radiotherapyE Sisti, F Menconi, M Leo, et al.
The Journal of Clinical Endocrinology and Metabolism|August 15, 2001
Comparison of the effectiveness and tolerability of intravenous or oral glucocorticoids associated with orbital radiotherapy in the management of severe Graves' ophthalmopathy: results of a prospective, single-blind, randomized studyC Marcocci, L Bartalena, M L Tanda, et al.
Journal of Endocrinological Investigation|July 29, 2016
Statins are not a risk factor for liver damage associated with intravenous glucocorticoid pulse therapy for Graves' orbitopathyE Sabini, E Sisti, B Coco, et al.
Biochimica Et Biophysica Acta|December 3, 2014
NADPH oxidase activation and 4-hydroxy-2-nonenal/aquaporin-4 adducts as possible new players in oxidative neuronal damage presents in drug-resistant epilepsyA Pecorelli, F Natrella, G Belmonte, et al.
Journal of Endocrinological Investigation|July 22, 2019
Features and outcome of differentiated thyroid carcinoma associated with Graves' disease: results of a large, retrospective, multicenter studyP Premoli, M L Tanda, E Piantanida, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|July 20, 2014
Recommendations of the Sleep Study Group of the Italian Dementia Research Association (SINDem) on clinical assessment and management of sleep disorders in individuals with mild cognitive impairment and dementia: a clinical reviewB Guarnieri, M Musicco, P Caffarra, et al.
Pageof 9

Showing results (71-80 of 81) with videos related to

Sort By:
Pageof 9
The Journal of Clinical Endocrinology and Metabolism|January 22, 1998
Outcome of thyroid function in Graves' patients treated with radioiodine: role of thyroid-stimulating and thyrotropin-blocking antibodies and of radioiodine-induced thyroid damageL Chiovato, E Fiore, P Vitti, et al.
Revue D'Electroencephalographie Et De Neurophysiologie Clinique|December 1, 1983
EEG sleep patterns and endogenous opioids in infants of narcotic-addicted mothersL G Manfredi, R Rocchi, A E Panerai, et al.
Neurology|July 17, 1999
A new CACNA1A gene mutation in acetazolamide-responsive familial hemiplegic migraine and ataxiaS Battistini, S Stenirri, M Piatti, et al.
Journal of Endocrinological Investigation|June 21, 2018
Relationship between serum cholesterol and Graves' orbitopathy (GO): a confirmatory studyG Lanzolla, E Sabini, M A Profilo, et al.
Journal of Endocrinological Investigation|January 19, 2015
Long-term outcome of Graves' orbitopathy following high-dose intravenous glucocorticoids and orbital radiotherapyE Sisti, F Menconi, M Leo, et al.
The Journal of Clinical Endocrinology and Metabolism|August 15, 2001
Comparison of the effectiveness and tolerability of intravenous or oral glucocorticoids associated with orbital radiotherapy in the management of severe Graves' ophthalmopathy: results of a prospective, single-blind, randomized studyC Marcocci, L Bartalena, M L Tanda, et al.
Journal of Endocrinological Investigation|July 29, 2016
Statins are not a risk factor for liver damage associated with intravenous glucocorticoid pulse therapy for Graves' orbitopathyE Sabini, E Sisti, B Coco, et al.
Biochimica Et Biophysica Acta|December 3, 2014
NADPH oxidase activation and 4-hydroxy-2-nonenal/aquaporin-4 adducts as possible new players in oxidative neuronal damage presents in drug-resistant epilepsyA Pecorelli, F Natrella, G Belmonte, et al.
Journal of Endocrinological Investigation|July 22, 2019
Features and outcome of differentiated thyroid carcinoma associated with Graves' disease: results of a large, retrospective, multicenter studyP Premoli, M L Tanda, E Piantanida, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|July 20, 2014
Recommendations of the Sleep Study Group of the Italian Dementia Research Association (SINDem) on clinical assessment and management of sleep disorders in individuals with mild cognitive impairment and dementia: a clinical reviewB Guarnieri, M Musicco, P Caffarra, et al.
Pageof 9